News | Radiation Therapy | May 20, 2016

Keynote speakers to include former HHS Secretary Sebelius, Delta Airlines safety executive and Massachusetts General Hospital physicians group CEO

May 20, 2016 — Registration opened this week for the American Society for Radiation Oncology’s (ASTRO) 58th Annual Meeting, Sept. 25-28 at the Boston Convention and Exhibition Center.

This year’s meeting will feature a record number of abstracts, scientific and educational presentations on radiation oncology clinical trials, and research and keynote addresses from former U.S. Secretary of Health and Human Services Kathleen Sebelius, the current chair and CEO of the Massachusetts General Physicians Organization, and a top safety executive from Delta Air Lines.

The meeting is expected to attract more than 11,000 attendees from across the globe, including oncologists from all disciplines and members of the entire radiation oncology team.

Led by ASTRO President David C. Beyer, M.D., FASTRO, the 2016 meeting is organized around the theme, “Enhancing Value, Improving Outcomes,” echoing growing calls from policy makers, physicians and patients for value-based healthcare. “The goal of ASTRO’s 2016 Annual Meeting is to highlight the latest scientific and technological advances while emphasizing the importance of radiation oncology in providing value to cancer patients through cure and palliation,” said Beyer.

Three keynote addresses will examine various aspects of value in healthcare, such as safety, quality and access. Keynote speakers include:

  • Kathleen Sebelius, former U.S. Secretary of Health and Human Services;
  • Thomas James Lynch Jr., M.D., chair and chief executive officer, Massachusetts General Physicians Organization; and
  • Jason Ragogna, general manager, SMS and safety alliances, corporate safety, security and compliance, Delta Air Lines Inc.

The Presidential Symposium, “Prostate Cancer: Defining Value and Delivering It,” will feature Louis Potters, M.D., FASTRO, and Jeff M. Michalski, M.D., FASTRO, to highlight recent practice-changing landmark studies and current developments in the value-based care for prostate cancer.

Concurrent with the scientific and educational program, more than 200 exhibitors will demonstrate the latest cutting-edge technology and medical device innovations for radiation oncology.

For more information: www.astro.org


Related Content

News | Artificial Intelligence

March 28, 2024 — As artificial intelligence (AI) makes its way into cancer care – and into discussions between ...

Time March 28, 2024
arrow
News | Prostate Cancer

March 27, 2024 — A minimally invasive treatment using MRI and transurethral ultrasound instead of surgery or radiation ...

Time March 27, 2024
arrow
Videos | Radiation Oncology

In the conclusion of this 3-part video series on recent advancements in diagnostic radiology, current editorial advisory ...

Time March 19, 2024
arrow
News | Breast Imaging

March 18, 2024 — QT Imaging Holdings, Inc., a medical device company engaged in research, development, and ...

Time March 18, 2024
arrow
Feature | Radiation Oncology | By Christine Book

Appreciating the considerable advances in the clinical application of artificial intelligence (AI) within healthcare ...

Time March 06, 2024
arrow
News | FDA

March 1, 2024 — Varian, a Siemens Healthineers company, announced that it has received 510(k) clearance from the U.S ...

Time March 01, 2024
arrow
News | Breast Imaging

February 22, 2024 — The FAST-Forward randomized trial from the UK found that ultrahypofractionated whole breast ...

Time February 22, 2024
arrow
News | Radiation Oncology

February 22, 2024 — The National Institutes of Health has launched a clinical trials network to evaluate emerging ...

Time February 22, 2024
arrow
News | Radiation Oncology

February 14, 2024 — Accuray Incorporated announced that the team at Quebec’s Montérégie Integrated Cancer Center, part ...

Time February 14, 2024
arrow
News | Radiation Oncology

February 12, 2024 — Radformation, a global pioneer in radiation oncology software solutions, is pleased to announce its ...

Time February 12, 2024
arrow
Subscribe Now